Ception Therapeutics Overview

  • Founded
  • 2004

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $250M

Ception Therapeutics General Information


Developer of biopharmaceuticals engaged in the discovery, development, and commercialization of new drugs and therapies for difficult to treat illnesses. The company offers Reslizumab for eosinophilic inflammatory conditions. It also provides Anti-TNF, a class of small molecule anti-TNF receptor agents with the potential to be orally administered. The companies portfolio includes treatments for central nervous system disorders, pain and cancer and include eight proprietary products in the United States, along with more than 100 products internationally. Cephalon's research pipeline is focused on developing new compounds and new indications for existing products, while their business collaborations capitalize on new products and smart drug delivery technologies.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • 101 Lindenwood Drive
  • Suite 400
  • Malvern, PA 19355
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ception Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 05-Apr-2010 $250M 00000 00000 Completed Clinical Trials - Phase 2
5. Later Stage VC 14-Oct-2008 0000 00000 Completed Startup
4. Later Stage VC (Series C) 31-May-2007 0000 0000 Completed Startup
3. Early Stage VC (Series B) Completed Startup
2. Early Stage VC (Series A) Completed Startup
1. Accelerator/Incubator Completed Startup
To view Ception Therapeutics’s complete valuation and funding history, request access »

Ception Therapeutics Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aperture Venture Partners Venture Capital Minority 000 0000 000000 0
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
EW Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
Greenlight Capital Hedge Fund Minority 000 0000 000000 0
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Ception Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (0000 01-Dec-2005 0000000000 Discovery Tools (Healthcare)
To view Ception Therapeutics’s complete acquisitions history, request access »